Wearable Injectors Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Jun 2018| TMR652A| Transparency

Report Highlights

Wearable Injectors Market - Overview
This report studies the current as well as future prospects of the global wearable injectors market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of wearable injectors for cancer and diabetes treatment, and new players planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global wearable injectors market with respect to the leading segments based on type, application, end-uses, and region.

Based on type, the global wearable injectors market has been categorized into on-body wearable injectors and off-body wearable injectors. In terms of application, the market has been classified into oncology, diabetes, autoimmune disorders, cardiovascular diseases, infectious diseases, and others. Based on end-user, the global wearable injectors market has been divided into hospitals, clinics, home care settings, and others. Each of the segments has been extensively analyzed based on market related factors such as incidence and prevalence of cancer, diabetes, autoimmune disorders, cardiovascular diseases, and infectious diseases. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

The overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the wearable injectors market and could influence the market in the near future. Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition in the market across different regions. The competitive scenario among different market players has been evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global wearable injectors market.

Geographically, the global wearable injectors market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s Five Forces Analysis, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global wearable injectors market.

Key players operating in the global wearable injectors market are Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., Insulet Corporation, Ypsomed AG, West Pharmaceutical Services, Inc., CeQur SA., Debiotech S.A., Sensile Medical AG, and SteadyMed Therapeutics, Inc., among others.

The global wearable injectors market has been segmented as follows:

Global Wearable Injectors Market, by Type
On-body Wearable Injectors
Off-body Wearable Injectors

Global Wearable Injectors Market, by Application
Oncology
Diabetes
Autoimmune Disorders
Cardiovascular Diseases
Infectious Diseases
Others

Global Wearable Injectors Market, by End-user
Hospitals
Clinics
Home Care Settings
Others

Global Wearable Injectors Market, by Region
North America
U.S.
Canada
Europe
Germany
France
Italy
Spain
U.K.
Rest of Europe
Asia Pacific
India
Japan
China
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Global Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
  • Table 2 : Global Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 3 : Global Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 4 : Global Wearable Injectors Market Revenue (US$ Mn) Forecast, by Region, 2016–2026
  • Table 5 : North America Wearable Injectors Market Size (US$ Mn) Forecast, by Country, 2016–2026
  • Table 6 : North America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
  • Table 7 : North America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 8 : North America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 9 : Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 10 : Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
  • Table 11 : Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 12 : Europe Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 13 : Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 14 : Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
  • Table 15 : Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 16 : Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 17 : Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 18 : Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
  • Table 19 : Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 20 : Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 21 : Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 22 : Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
  • Table 23 : Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 24 : Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Figure 1 : Global Wearable Injectors Market Snapshot
  • Figure 2 : Global Wearable Injectors Market Size (US$ Mn) Forecast, 2016–2026
  • Figure 3 : Market Value Share, by Type (2017)
  • Figure 4 : Market Value Share, by Application (2017)
  • Figure 5 : Market Value Share, by Region (2017)
  • Figure 6 : Figure 6: Market Value Share, by End-user (2017)
  • Figure 7 : Global Wearable Injectors Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 8 : Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by On-body wearable injectors, 2016–2026
  • Figure 9 : Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Off-body wearable injectors, 2016–2026
  • Figure 10 : Global Wearable Injectors Market Attractiveness Analysis, by Type, 2016–2026
  • Figure 11 : Global Wearable Injectors Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 12 : Global Wearable Injectors Market Size (US$ Mn), by Oncology, 2016–2026
  • Figure 13 : Global Wearable Injectors Market Size (US$ Mn), by Diabetes, 2016–2026
  • Figure 14 : Global Wearable Injectors Market Size (US$ Mn), by Autoimmune Disorders, 2016–2026
  • Figure 15 : Global Wearable Injectors Market Size (US$ Mn), by Cardiovascular Diseases, 2016–2026
  • Figure 16 : Global Wearable Injectors Market Size (US$ Mn), by Infectious Diseases, 2016–2026
  • Figure 17 : Global Wearable Injectors Market Size (US$ Mn), by Others, 2016–2026
  • Figure 18 : Global Wearable Injectors Market Attractiveness Analysis, by Application, 2018–2026
  • Figure 19 : Global Wearable Injectors Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 20 : Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2016–2026
  • Figure 21 : Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Clinics, 2016–2026
  • Figure 22 : Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Home Care Settings, 2016–2026
  • Figure 23 : Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Others (Physician office, etc.), 2016–2026
  • Figure 24 : Global Wearable Injectors Market Attractiveness Analysis, by End-user, 2016–2026
  • Figure 25 : Global Wearable Injectors Market Value Share, by Region, 2017 and 2026
  • Figure 26 : Global Wearable Injectors Market Attractiveness, by Region, 2018–2026
  • Figure 27 : North America Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 28 : North America Wearable Injectors Market Attractiveness, by Country, 2018–2026
  • Figure 29 : North America Wearable Injectors Market Value Share, by Country, 2017 and 2026
  • Figure 30 : North America Wearable Injectors Market Value Share, by Type, 2017 and 2026
  • Figure 31 : North America Wearable Injectors Market Value Share, by Application, 2017 and 2026
  • Figure 32 : North America Wearable Injectors Market Value Share, by End-user, 2017 and 2026
  • Figure 33 : North America Wearable Injectors Market Attractiveness, by Type, 2016–2026
  • Figure 34 : North America Wearable Injectors Market Attractiveness, by End-user, 2016–2026
  • Figure 35 : North America Wearable Injectors Market Attractiveness, by Application, 2016–2026
  • Figure 36 : Europe Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 37 : Europe Wearable Injectors Market Attractiveness, by Country, 2018–2026
  • Figure 38 : Europe Wearable Injectors Market Value Share, by Country, 2017 and 2026
  • Figure 39 : Europe Wearable Injectors Market Value Share, by Type, 2017 and 2026
  • Figure 40 : Europe Wearable Injectors Market Value Share, by Application, 2017 and 2026
  • Figure 41 : Europe Wearable Injectors Market Value Share, by End-user, 2017 and 2026
  • Figure 42 : Europe Wearable Injectors Market Attractiveness, by Type, 2016–2026
  • Figure 43 : Europe Wearable Injectors Market Attractiveness, by End-user, 2016–2026
  • Figure 44 : Europe Wearable Injectors Market Attractiveness, by Application, 2016–2026
  • Figure 45 : Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 46 : Asia Pacific Wearable Injectors Market Attractiveness, by Country, 2018–2026
  • Figure 47 : Asia Pacific Wearable Injectors Market Value Share, by Country, 2017 and 2026
  • Figure 48 : Asia Pacific Wearable Injectors Market Value Share, by Type, 2017 and 2026
  • Figure 49 : Asia Pacific Wearable Injectors Market Value Share, by Application, 2017 and 2026
  • Figure 50 : Asia Pacific Wearable Injectors Market Value Share, by End-user, 2017 and 2026
  • Figure 51 : Asia Pacific Wearable Injectors Market Attractiveness, by Type, 2016–2026
  • Figure 52 : Asia Pacific Wearable Injectors Market Attractiveness, by End-user, 2016–2026
  • Figure 53 : Asia Pacific Wearable Injectors Market Attractiveness, by Application, 2016–2026
  • Figure 54 : Latin America Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 55 : Latin America Wearable Injectors Market Attractiveness, by Country, 2018–2026
  • Figure 56 : Latin America Wearable Injectors Market Value Share, by Country, 2017 and 2026
  • Figure 57 : Latin America Wearable Injectors Market Value Share, by Type, 2017 and 2026
  • Figure 58 : Latin America Wearable Injectors Market Value Share, by Application, 2017 and 2026
  • Figure 59 : Latin America Wearable Injectors Market Value Share, by End-user, 2017 and 2026
  • Figure 60 : Latin America Wearable Injectors Market Attractiveness, by Type, 2016–2026
  • Figure 61 : Latin America Wearable Injectors Market Attractiveness, by End-user, 2016–2026
  • Figure 62 : Latin America Wearable Injectors Market Attractiveness, by Application, 2016–2026
  • Figure 63 : Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 64 : Middle East & Africa Wearable Injectors Market Attractiveness, by Country, 2018–2026
  • Figure 65 : Middle East & Africa Wearable Injectors Market Value Share, by Country, 2017 and 2026
  • Figure 66 : Middle East & Africa Wearable Injectors Market Value Share, by Type, 2017 and 2026
  • Figure 67 : Middle East & Africa Wearable Injectors Market Value Share, by Application, 2017 and 2026
  • Figure 68 : Middle East & Africa Wearable Injectors Market Value Share, by End-user, 2017 and 2026
  • Figure 69 : Middle East & Africa Wearable Injectors Market Attractiveness, by Type, 2016–2026
  • Figure 70 : Middle East & Africa Wearable Injectors Market Attractiveness, by End-user, 2016–2026
  • Figure 71 : Middle East & Africa Wearable Injectors Market Attractiveness, by Application, 2016–2026
  • Figure 72 : Becton, Dickinson and Company, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 73 : Becton, Dickinson and Company, Breakdown of Net Sales, By Region (Pharmaceutical Segment), 2017
  • Figure 74 : Becton, Dickinson and Company, R&D Intensity (%) – Company Level or Segment Level, 2014–2017
  • Figure 75 : Hoffmann-La Roche Ltd., Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
  • Figure 76 : Hoffmann-La Roche Ltd., Breakdown of Net Sales, By Region (Pharmaceutical Segment), 2017
  • Figure 77 : Hoffmann-La Roche Ltd., R&D Intensity (%) – Company Level or Segment Level, 2014–2017
  • Figure 78 : Tandem Diabetes Care, Inc., R&D Intensity (%) – Company Level or Segment Level, 2014–2017
  • Figure 79 : Tandem Diabetes Care, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
  • Figure 80 : Insulet Corporation, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 81 : Insulet Corporation, Breakdown of Net Sales, By Region, 2016
  • Figure 82 : Insulet Corporation, R&D Intensity (%) – Company Level or Segment Level, 2014–2017
  • Figure 83 : Ypsomed AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 84 : Ypsomed AG, Breakdown of Net Sales, By Region, 2016
  • Figure 85 : Ypsomed AG, R&D Intensity (%) – Company Level or Segment Level, 2013–2016
  • Figure 86 : West Pharmaceutical Services, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
  • Figure 87 : West Pharmaceutical Services, Inc., Breakdown of Net Sales, By Region, 2016
  • Figure 88 : West Pharmaceutical Services, Inc., R&D Intensity (%) – Company Level or Segment Level, 2014–2017

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report